Epilepsy Market Size and Forecasts (2020-2030)

According to our new research study on “Epilepsy Market Forecast to 2030 – Global Analysis – by Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography,” the market is expected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is estimated to record a CAGR of 4.1% from 2022–2030. Key factors driving the growth of the epilepsy market are the rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies. However, the recall of products hinders the growth of the market.

Gene therapies are being explored as potential treatment options for certain genetic epilepsies. This innovative approach is aimed at treating diseases by modifying or manipulating the genetic makeup of cells. The fundamental principle of gene therapy is to correct or replace faulty genes that contribute to the development or progression of a particular condition. Since epileptic seizures are caused by excessive brain cell activity (neurons) in particular parts of the organ, targeting these neurons and turning them off could help prevent seizures. Two standard gene therapy techniques that can be employed to design an epilepsy treatment are gene addition and gene editing. Gene addition involves adding genetic material to an individual’s cells to balance a missing or abnormal gene, while gene editing involves treating genetic epilepsy by directly modifying an individual’s gene. By targeting specific genes associated with epilepsy and manipulating cellular genetic material, gene therapy can help restore normal cellular function and inhibit seizure generation.
Examining the genetic causes of a condition allows healthcare providers to offer more personalized and targeted treatment approaches. In cases involving heritable mutations, this knowledge aids in understanding the risks for affected families and facilitates genetic counseling, followed by informed decision-making. Ongoing advancements in the identification of genetic factors causing epilepsy to play a crucial role in guiding the medical care and management of affected individuals. Next-generation sequencing has largely driven significant progress in the field of genetics. This high-throughput genetic sequencing technique enables a faster and more comprehensive analysis of DNA, thereby aiding the identification of genetic causes of conditions such as epilepsy.
The continued progress in genetic research holds the potential to improve the care and support provided to individuals with epilepsy and their families. By targeting genes associated with ion channels, neurotransmitter receptors, or cellular signaling pathways, researchers can investigate how alterations in these genes contribute to epileptogenesis.
Although gene therapy for epilepsy is still in the early stages of development, preclinical studies in animal models have shown promising results. Animal models with specific epilepsy-related genetic mutations have been treated using gene therapy approaches, resulting in reduced seizure frequency and improved seizure control. In December 2023, UCL Queen Square Institute of Neurology researchers developed a new gene therapy to cure a devastating form of childhood epilepsy, which has been shown to notably reduce seizures in mice. They assessed a gene therapy based on the overexpression of a potassium channel that controls neuronal excitability in a mouse model with focal cortical dysplasia in the frontal lobe. The researchers injected an engineered potassium channel gene termed EKC into the affected frontal lobe of epileptic mice. They employed a virus lacking replicability as a vector to carry the potassium channel gene. The researchers found that gene therapy lowered seizures by an average of 87% compared to the control group without altering the mouse’s memory or behavior. Taking into account the unmet needs in epilepsy therapeutics, it can be utilized to treat children who are severely affected by uncontrolled seizures.
Many gene therapy trials for the treatment of epilepsy are currently underway or in the planning stages. The purpose of these trials is to estimate the safety and effectiveness of gene therapies in human patients with specific genetic forms of epilepsy. CombiGene’s CG01 is an appropriate drug candidate for treating epilepsy. It is an AAV-based gene therapy that has the potential to enhance the quality of life for people with drug-resistant focal epilepsy, for which no effective treatment is available currently. The therapy candidate CG01 uses a gene therapy vector to deliver a combination of neuropeptide Y and its receptor Y2 directly to the area of the brain that triggers epileptic seizures.
Thus, gene therapy is likely to serve as a promising new trend in the epilepsy market in the coming years.

Based on distribution channel, the epilepsy market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest epilepsy market share in 2022. Hospital pharmacies are an essential aspect of patient care at a healthcare facility. Pharmaceuticals are purchased, stored, compounded, dispensed, manufactured, tested, packaged, and distributed in these departments in hospitals. Controlling the use of pharmaceuticals in hospitals and other medical facilities is the primary responsibility of hospital pharmacies. They aim to improve patient outcomes through the selection, prescription, procurement, delivery, administration, and review of pharmaceuticals.
Hospital pharmacies purchase pharmaceuticals from different companies and supply them for outpatient or inpatient treatments. They usually offer therapeutic and critical care drugs that have cardiology, neurology, urology, pathology, hematology, and dermatology applications. These pharmacies maintain stocks of epilepsy drugs to ensure their ready availability for patients. Thus, the hospital pharmacies segment accounts for a considerable size of the epilepsy market.
In addition, the retail pharmacies segment is expected to register the highest CAGR in the epilepsy market during 2022–2030. Retail pharmacy stores sell prescription drugs, over-the-counter drugs, and some fast-moving consumer goods, along with providing related services. Modern retail pharmacy chains are digitized, organized, and tech-enabled, which allows them to track medication inventories and sell 100% reliable goods. In addition, retail pharmacy chains provide value-added services for consumers opting for medical claims or insurance filings. They can also be requested to refurbish previous bills or memos. Moreover, their locations make them accessible for patients to fill their prescriptions and receive counseling from pharmacists.

Abbott Laboratories, Pfizer Inc, Eisai Co Ltd, UCB SA, CombiGene AB, Livanova PLC, Novartis AG, Medtronic PLC, GSK PLC, and H. Lundbeck AS are among the leading companies profiled in the epilepsy market report.

Epilepsy Market, by Region, 2022(%)

Source: the research team Analysis

Based on type, the epilepsy market is categorized into progressive myoclonic epilepsy, generalized epilepsy, reflex epilepsy, and others. In terms of route of administration, the market is classified into oral, parenteral, and others. The market, by treatment type, is segmented into first-generation drugs, second-generation drugs, and third-generation drugs. In terms of age group, the epilepsy market is bifurcated into adults and children. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and others. Based on geography, the epilepsy market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America.

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Epilepsy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Epilepsy Market – Key Market Dynamics
5.1 Epilepsy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Epilepsy
5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
5.3.1 Recall of Products
5.4 Market Opportunities
5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:
6. Epilepsy Market – Global Market Analysis
6.1 Epilepsy Market Revenue (US$ Million), 2022–2030
7. Epilepsy Market Analysis – by Type
7.1 Overview
7.2 Progressive Myoclonic Epilepsy
7.2.1 Overview
7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
7.3.1 Overview
7.3.2 Reflex Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
7.4.1 Overview
7.4.2 Generalized Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Other
7.5.1 Overview
7.5.2 Other: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8. Epilepsy Market Analysis – by Route of Administration
8.1 Overview
8.2 Oral
8.2.1 Overview
8.2.2 Oral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9. Epilepsy Market Analysis – by Treatment Type
9.1 Overview
9.2 First Generation Drugs
9.2.1 Overview
9.2.2 First Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
9.3.1 Overview
9.3.2 Second Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
9.4.1 Overview
9.4.2 Third Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
10. Epilepsy Market Analysis – by Age Group
10.1 Overview
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Children
10.3.1 Overview
10.3.2 Children: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11. Epilepsy Market Analysis – by Distribution Channel
11.1 Overview
11.2 Hospital Pharmacies
11.2.1 Overview
11.2.2 Hospital Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12. Epilepsy Market – Geographical Analysis
12.1 North America: Epilepsy Market
12.1.1 Overview
12.1.2 North America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.2.1 North America: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.1.2.2 North America: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.1.2.3 North America: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.1.2.4 North America: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.1.2.5 North America: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.1.3 North America: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.1.3.1 United States: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.1 Overview
12.1.3.1.2 United States: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.2 Canada: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.2.1 Overview
12.1.3.3 Canada: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
12.1.3.4 Mexico: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.4.1 Overview
12.1.3.5 Mexico: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
12.2.1 Overview
12.2.2 Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.2.1 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.2.2.2 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.2.2.3 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.2.2.4 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.2.2.5 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.2.3 Europe: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.2.3.1 United Kingdom: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.1.1 Overview
12.2.3.2 United Kingdom: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.3 Germany: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.3.1 Overview
12.2.3.4 Germany: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.5 France: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.5.1 Overview
12.2.3.6 France: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.7 Spain: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.7.1 Overview
12.2.3.8 Spain: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.9 Italy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.9.1 Overview
12.2.3.10 Italy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
12.2.3.11 Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.11.1 Overview
12.2.3.12 Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
12.3.1 Overview
12.3.2 Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.2.1 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.3.2.2 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.3.2.3 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.3.2.4 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.3.2.5 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.3.3 Asia Pacific: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.3.3.1 China: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.1.1 Overview
12.3.3.2 China: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.3 Japan: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.3.1 Overview
12.3.3.4 Japan: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.5 India: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.5.1 Overview
12.3.3.6 India: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.7 Australia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.7.1 Overview
12.3.3.8 Australia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.9 South Korea: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.9.1 Overview
12.3.3.10 South Korea: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
12.3.3.11 Rest of Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.11.1 Overview
12.3.3.12 Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
12.4.1 Overview
12.4.2 Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.2.1 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.4.2.2 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.4.2.3 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.4.2.4 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.4.2.5 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.4.3 Middle East and Africa: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.4.3.1 Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.1.1 Overview
12.4.3.2 Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.3 South Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.3.1 Overview
12.4.3.4 South Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.5 United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.5.1 Overview
12.4.3.6 United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
12.4.3.7 Rest of Middle East & Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.7.1 Overview
12.4.3.8 Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
12.5.1 Overview
12.5.2 South and Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.2.1 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Type
12.5.2.2 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Route of Administration
12.5.2.3 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Treatment Type
12.5.2.4 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Age Group
12.5.2.5 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Distribution Channel
12.5.3 South and Central America: Epilepsy Market – Revenue and Forecast Analysis – by Country
12.5.3.1 Brazil: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.1.1 Overview
12.5.3.2 Brazil: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.3 Argentina: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.3.1 Overview
12.5.3.4 Argentina: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
12.5.3.5 Rest of South & Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.5.1 Overview
12.5.3.6 Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Pfizer Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Eisai Co Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 UCB SA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CombiGene AB
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 LivaNova Plc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Medtronic Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GSK Plc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 H. Lundbeck AS
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners

Table 1. Epilepsy Market Segmentation
Table 2. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 3. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 4. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 5. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 6. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 7. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 8. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 10. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 11. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 12. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 13. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 15. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 16. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 17. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 18. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 19. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 20. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 21. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 22. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 23. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 24. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 25. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 26. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 27. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 28. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 29. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 30. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 31. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 32. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 33. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 34. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 35. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 36. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 37. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 38. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 40. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 41. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 42. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 43. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 44. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 45. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 46. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 47. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 48. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 49. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 50. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 51. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 52. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 53. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 54. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 55. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 56. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 57. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 58. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 59. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 60. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 61. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 62. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 63. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 65. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 66. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 67. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 68. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 69. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 70. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 71. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 72. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 73. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 74. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 75. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 76. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 78. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 79. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 80. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 81. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 82. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 83. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 84. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 85. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 86. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 87. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 88. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 90. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 91. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 92. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 93. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 94. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 95. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 96. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 97. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 98. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 99. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 100. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 101. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 103. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 104. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 105. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 106. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 107. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 108. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 109. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 110. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 111. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 112. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 113. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 114. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 115. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 116. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 117. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 118. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 119. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 120. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 121. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 122. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 123. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 124. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 125. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 126. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 127. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 128. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 129. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 130. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 131. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 132. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 133. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 134. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Treatment Type
Table 135. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Age Group
Table 136. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 137. Recent Organic Growth Strategies in Epilepsy Market
Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market

Figure 1. Epilepsy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Epilepsy Market Revenue (US$ Million), 2022–2030
Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 6. Epilepsy Market Share (%) – by Type (2022 and 2030)
Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Reflex Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Generalized Epilepsy: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Other: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Epilepsy Market Share (%) – by Route of Administration (2022 and 2030)
Figure 12. Oral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy Market Share (%) – by Treatment Type (2022 and 2030)
Figure 16. First Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Second Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Third Generation Drugs: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy Market Share (%) – by Age Group (2022 and 2030)
Figure 20. Adult: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Children: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Epilepsy Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 23. Hospital Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Pharmacies: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 27. North America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 33. Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 42. Asia Pacific: Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East & Africa: Epilepsy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 54. South Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 57. South & Central America: Epilepsy Market, By Key Country – Revenue (2022) (US$ Million)
Figure 58. South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Epilepsy Market – Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in Epilepsy Market